Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KERX | XFOR | IMRX | ||
| Company | Keryx Biopharm Inc | X4 Pharmaceuticals Inc | Immuneering Corp Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.44 | 3.85 | 5.28 | ||
| High | 3.46 | 4.17 | 5.50 | ||
| Low | 2.96 | 3.85 | 5.27 | ||
| Latest | 3.36 | 4.09 | 5.32 | ||
| Change | -0.07 | +0.27 | +0.09 | ||
| % Change | -2.04% | +7.07% | +1.72% | ||
| Volume | 2,596,000 | 402,500 | 545,500 | ||
| 20-Day Average Volume | 1,773,160 | 578,330 | 1,205,845 | ||
| Previous Close | 3.43 | 3.82 | 5.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.97 | 3.87 | 5.14 | ||
| 20-Day Raw Stochastic | 85.58% | 54.60% | 56.52% | ||
| 20-Day Relative Strength | 57.59 | 53.94 | 52.30 | ||
| Weighted Alpha | -32.40 | -41.51 | +71.89 | ||
| Today's Opinion | N/A | 88% Buy | 32% Sell | ||
| Previous Opinion | N/A | 72% Buy | 32% Sell | ||
| Last Month's Opinion | N/A | 8% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.53% since 12/04/18 | +0.99% since 03/18/26 | +11.30% since 03/18/26 | ||
| Low | 2.95 on 12/06/18 | 3.81 on 03/24/26 | 4.67 on 03/19/26 | ||
| High | 3.51 on 12/11/18 | 4.50 on 03/20/26 | 5.50 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +16.26% since 11/12/18 | +18.90% since 02/25/26 | +1.53% since 02/25/26 | ||
| Low | 2.47 on 11/21/18 | 3.20 on 02/27/26 | 4.67 on 03/19/26 | ||
| High | 3.51 on 12/11/18 | 4.83 on 03/10/26 | 5.82 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +12.37% since 09/12/18 | -7.47% since 12/24/25 | -21.88% since 12/24/25 | ||
| Low | 2.47 on 11/21/18 | 2.83 on 02/18/26 | 4.04 on 01/13/26 | ||
| High | 3.65 on 11/09/18 | 4.83 on 03/10/26 | 8.48 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | -33.60% since 06/12/18 | +21.01% since 09/25/25 | -33.50% since 09/25/25 | ||
| Low | 2.47 on 11/21/18 | 2.80 on 10/15/25 | 4.04 on 01/13/26 | ||
| High | 5.30 on 06/20/18 | 4.83 on 03/10/26 | 8.48 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 343,997 | 347,314 | 338,135 | ||
| Shares Outstanding, K | 102,380 | 90,920 | 64,653 | ||
| Annual Sales | 60,640,000 | 35,110,000 | 0 | ||
| Annual Net Income | -163,440,000 | -79,200,000 | -56,020,000 | ||
| Last Quarter Sales | 28,040,000 | 2,570,000 | 0 | ||
| Last Quarter Net Income | -17,000,000 | -23,930,000 | -11,580,000 | ||
| 60-Month Beta | 2.35 | 0.43 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/07/18 | -0.22 on 03/17/26 | -0.18 on 03/06/26 | ||
| Latest Earnings Date | 02/06/19 | 05/07/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||